ABCB1 and cancer: This type of mitochondria-targeted NO delivery is critical in inducing mitochondrial dysfunction by facilitating the membrane permeabilization of mitochondria and decreasing ATP levels, which can inhibit the bioactivities associated with P-glycoprotein and the formation of tumor-derived microvesicles, thereby combating cancer metastasis and drug resistance.